BURLINGAME, Calif. & BETHLEHEM, Pa.--(BUSINESS WIRE)--Berkeley HeartLab (BHL), a subsidiary of Celera Corporation (NASDAQ:CRA), announced today that it has entered into collaborative agreements with Geisinger Medical Center and Proven Diagnostics, a clinical laboratory service recently launched by Geisinger Health System.
